Portola Pharma (PTLA) Receives CRL from FDA for Andexanet Alfa
Tweet Send to a Friend
Portola Pharmaceuticals Inc. (Nasdaq: PTLA) announced that it has received a Complete Response Letter (CRL) from the U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE